The Women’s Bureau, U. S. Department of Labor announces the availability of approximately $1 million in grant funds authorized by 29 U.S.C.
§ 13 and the 2016 Consolidated Appropriations Act, for the Women’s Bureau Paid Leave Analysis grant program.
This program is intended to
support research and analysis needed to explore, develop, implement, and/or improve paid family and medical leave programs at the State and municipal levels, as well as in U. S. Territories and Possessions and federally recognized Indian/Native American Tribes.
Specifically, the research and analysis activities must fall into one or more of the following five categories:
• Statistical analysis, such as cost-benefit or actuarial studies; • Feasibility analysis; • Economic-impact analysis; • Financing, eligibility, and benefit modeling; and • Education, outreach, and marketing analysis for implementation purposes.
The activities listed above may include identifying and studying viable options for financing and administering a paid family and medical leave program in states that do not have a temporary disability insurance program (e.g., employer mandates; other social insurance programs; publicly funded programs).
Additionally, eligible entities that have already completed the analyses listed above and are awaiting legislative action to formally adopt or have recently adopted a paid family and medical leave program may apply for funds to support pre-implementation or initial implementation analyses, including but not limited to:
• Identifying requirements for administration of a state-level paid leave program, such as an information technology plan or business processes and staffing needs for program administration; • Developing implementation plans, including education and outreach strategies; and • Conducting survey research to develop potential benchmarks to measure the impact of the policy or program at a later time.
Up to six (6) grants of no more than $250,000 each will be awarded.
The period of performance is twelve (12) months with an anticipated start date of October 1, 201 6. This performance period includes all necessary implementation and start-up activities.